Chronic cerebrovascular diseases: use of vinpocetine in neurological practice (Round Table proceedings)
https://doi.org/10.14412/2074-2711-2018-4-139-145
Abstract
The paper presents the proceedings of the Round Table with the participation of leading neurologists, which is devoted to chronic cerebrovascular diseases. It is noted that chronic cerebral ischemia (CCI), or dyscirculatory encephalopathy (DEP), is one of the most common neurological diagnoses in our country. The pathogenesis, clinical presentations, diagnosis and treatment of CCI (DEP) and its matching with vascular cognitive impairment (CI), which is regarded in foreign literature as the main manifestation of chronic cerebrovascular disease (CVD) were considered. The authors analyze clinical trials evaluating the efficacy of vinpocetine (Cavinton) in chronic CVD, dizziness, CI, as well as the use of new vinpocetine formulations, such as Cavinton Comforte, in various neurological diseases, dysphagia in particular, in poststroke patients.
About the Authors
V. A. ParfenovRussian Federation
Department of Nervous System Diseases and Neurosurgery, Faculty of General Medicine.
11, Rossolimo St., Build. 1, Moscow 119021
S. A. Zhivolupov
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044
V. V. Zakharov
Russian Federation
Department of Nervous System Diseases and Neurosurgery, Faculty of General Medicine.
11, Rossolimo St., Build. 1, Moscow 119021
L. A. Belova
Russian Federation
42, Lev Tolstoy St., Ulyanovsk 432017
O. V. Lagoda
Russian Federation
80, Volokolamskoe Shosse, Moscow 125367
R. G. Esin
Russian Federation
11, Mushtari St., Kazan 420012; 18, Kremlevskaya St., Kazan 420008
N. V. Vakhnina
Russian Federation
Department of Nervous System Diseases and Neurosurgery, Faculty of General Medicine.
11, Rossolimo St., Build. 1, Moscow 119021
I. N. Samartsev
Russian Federation
Department of Nervous System Diseases and Neurosurgery, Faculty of General Medicine.
11, Rossolimo St., Build. 1, Moscow 119021